Skip to main content

Table 3 Clinical outcomes, complications and mortality of the burn patients

From: Quantifying the impact of inhalational burns: a prospective study

 

Non-inhalational burns n = 167

Inhalational burns n = 35

p value, U

Number of surgery sessions, median (IQR)

1 (1–1)

3 (0–10)

0.003, U = 3552

Length of stay (days), median (IQR)

8 (5–12)

21 (4–43)

0.004, U = 3582

Average length of stay/%TBSA (sum of length of stay/sum of %TBSA)

1.307

0.976

NA

Length of ICU stay (days), median (IQR)

0 (0–0)

3 (0–10)

< 0.001, U = 4785

Average length of ICU stay/%TBSA (sum of length of ICU stay/sum of %TBSA)

0.020

0.313

NA

Days on IV antibiotics, median (IQR)

3 (1–6)

9.5 (0–28.25)

0.014, U = 3552

Average days on IV antibiotics/%TBSA (Sum of days of IV antibiotics/sum of %TBSA)

0.580

0.474

NA

Days of mechanical ventilation, median (IQR)

0 (0–0)

2 (0–10)

< 0.001

Initial P/F ratio, median (IQR)

532.6 (316.8–678.9)

370.4 (291.8–554.2)

0.191

Lowest P/F ratio in 2 days from admission, median (IQR)

518.5 (372.0–689.5)

253.6 (202.7–408.4)

0.026

Lowest P/F ratio in 7 days from admission, median (IQR)

518.5 (372.0–689.5)

246.8 (181.5–389.4)

0.018

Admission to HD, n (%)

46 (27.5)

31(88.6)

< 0.001

Admission to ICU, n (%)

10 (6.0)

22 (62.9)

< 0.001

Intubation, n (%)

4 (2.4)

22 (62.8)

< 0.001

Mortality, n (%)

1 (0.6)

6 (17.1)

< 0.001

AKI, n (%)

2 (1.2)

13 (37.1)

< 0.001

ARDS, n (%)

1 (0.6)

17 (48.6)

< 0.001

Bacteraemia, n (%)

4 (2.4)

11 (31.4)

< 0.001

Pneumonia, n (%)

2 (1.2)

13 (37.1)

< 0.001

Burn wound infection, n (%)

42 (25.1)

18 (51.4)

0.004

  1. %TBSA percentage of total body surface area, ARDS acute respiratory distress syndrome, AKI acute kidney injury, IV intravenous, ICU intensive care unit, NA not applicable, HD high dependency unit, IQR interquartile range, P/F PaO2 /FiO2